Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo — you do not prime the Mounjaro KwikPen before each injection. Priming is a one-time setup step carried out only on a brand-new pen, before its very first use. Every subsequent injection skips that step entirely. This is one of the most common points of confusion for people starting tirzepatide, and getting it wrong can affect the dose you actually receive.
Mounjaro is a prescription-only medicine, and the full injection technique (including when and how to prepare each pen) is set out in the Patient Information Leaflet supplied with your treatment. If anything feels unclear, your prescriber or pharmacist is the right person to ask before you inject.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: a new Mounjaro pen arrives, you've stored it in the fridge as directed, and now it's injection day. Before that first dose, you do need to prime, but only once, and only for this reason: the very tip of a fresh pen may have a tiny air bubble from the manufacturing and transport process. Priming pushes that bubble out so the full measured dose reaches you, not part-air.
The process involves attaching the needle, removing the inner needle cap, holding the pen with the needle pointing upward, and pressing the injection button until a small droplet of liquid appears at the needle tip. That droplet confirms the pen is ready. Once you see it, priming is complete.
After this first-dose setup, you inject as normal. From the second dose onward (and for every dose from every subsequent pen) no priming is needed. The pen's mechanism is already set; you attach a fresh needle, clear the injection site, and go. The full step-by-step priming process is worth reading through before your very first pen, so the sequence is clear in your head.
A question our prescribers hear most weeks is whether you prime the Mounjaro pen every time or only at the start of a new pen, and the short answer is: new pen, prime once. Used pen, don't prime at all.
Each KwikPen holds four weekly doses. Once you've completed the first injection and priming is behind you, the remaining three doses follow a simpler routine.
Before each of those subsequent injections, you still remove the purple flow-check cap from the pen body and then the inner needle cap from a fresh needle, you should be using a new needle for every injection to reduce the risk of blocked tips and skin reactions. You still clean the injection site. You still choose a spot on your abdomen, thigh, or upper arm, rotating each time to avoid injecting repeatedly into the same patch of skin.
What you do not do is repeat the upward-pointing, button-pressing, droplet-checking sequence. The pen's internal plunger advances by one dose each time you inject; attempting to "re-prime" it would push medicine out unnecessarily and mean your next dose is short. The Mounjaro injection guide covers site rotation and the full per-dose routine in more detail.
After the fourth dose, the pen locks. That is by design. Discard it in a sealed sharps container rather than in household waste.
Tirzepatide is a dual GIP and GLP-1 receptor agonist, it works by activating two distinct gut-hormone pathways that regulate appetite and blood-sugar signalling, as described in NHS guidance on tirzepatide. The dose delivered each week is calibrated precisely within that framework; even small deviations from the intended amount can affect how your body tolerates the medicine and how effective each stage of treatment is.
This is also why the titration schedule matters. Treatment typically begins at 2.5mg (a dose whose job is to let your system adjust, not to produce immediate weight change) before the prescriber steps it up over several weeks. Under-dosing at any point, including through a priming error on a mid-pen injection, disrupts that carefully paced process. If you are exploring more flexible or cost-effective ways to continue treatment, it is worth looking at what a tirzepatide injection generic involves and how it compares to the branded pen.
For a broader look at how the pen works and what to expect week by week, the Mounjaro treatment overview is a useful starting point. And if you're still deciding whether tirzepatide is the right direction for you, the weight-loss treatment page sets out the options.
One practical note: injection timing also matters for consistency. If you want to understand how flexible your weekly schedule can be, how fixed the injection day needs to be explains what the guidance says and where you have room to move.
The Patient Information Leaflet included with every pen is the definitive reference for technique, it covers storage temperatures, what to do if the liquid looks cloudy or discoloured, and what happens if you miss a dose. These are decisions for the leaflet and your prescriber, not a general article.
Storage is worth a quick mention here because it links directly to pen readiness. Mounjaro should be kept refrigerated at 2–8°C. If a pen has been out of the fridge, the SmPC sets the permitted room-temperature window; always check the Mounjaro SmPC on the eMC for the exact figures rather than relying on memory or informal sources.
If you notice anything unexpected (liquid that looks wrong, a pen that won't click, a site reaction that isn't settling) contact your prescriber before your next injection. At nume, our support team is available seven days a week for exactly this kind of question. When you're ready to take the next step, speaking to our prescribers is straightforward: free consultation, reviewed the same day by a GPhC-registered Independent Prescriber.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.